share_log

Guggenheim Initiates Coverage On Precision BioSciences With Buy Rating, Announces Price Target of $19

Guggenheim Initiates Coverage On Precision BioSciences With Buy Rating, Announces Price Target of $19

古根海姆以买入评级启动对精准生物科学的报道,宣布目标股价为19美元
Benzinga ·  04/30 07:41

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Buy rating and announces Price Target of $19.

古根海姆分析师德布吉特·查托帕迪亚以买入评级启动了对精准生物科学(纳斯达克股票代码:DTIL)的报道,并宣布目标股价为19美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发